CHAM, Switzerland, July 23 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its August 2024 edition (Vol. 38, Issue 8):

* The Use of Ketamine for the Treatment of Anhedonia in Depression

* The State of Synthetic Cannabinoid Medications for the Treatment of Pain